Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cross Country Healthcare | CCRN | Sep 30, 2024 | 13.44 | +1.90 |
Cross Timbers Royalty Royalty Trust | CRT | Sep 30, 2024 | 10.57 | +3.32 |
CrossAmerica Partners LP Unit | CAPL | Sep 30, 2024 | 20.72 | +0.10 |
CrossFirst Bankshares | CFB | Sep 30, 2024 | 16.69 | +1.83 |
CrowdStrike A | CRWD | Sep 30, 2024 | 280.47 | -1.89 |
Crown Castle | CCI | Sep 30, 2024 | 118.63 | +1.73 |
Crown Crafts | CRWS | Sep 30, 2024 | 4.80 | -0.21 |
Crown ElectroKinetics | CRKN | Sep 30, 2024 | 1.23 | 0.00 |
Crown Holdings | CCK | Sep 30, 2024 | 95.88 | +1.20 |
Crown LNG | CGBS | Sep 30, 2024 | 0.28 | 0.00 |
Cryo-Cell International | CCEL | Sep 30, 2024 | 6.37 | -1.70 |
CryoPort | CYRX | Sep 30, 2024 | 8.11 | +1.38 |
CS Disco | LAW | Sep 30, 2024 | 5.88 | +1.38 |
CSG Systems International | CSGS | Sep 30, 2024 | 48.65 | +1.16 |
CSP | CSPI | Sep 30, 2024 | 12.99 | +0.70 |
CSW Industrials | CSWI | Sep 30, 2024 | 366.39 | -0.90 |
CSX | CSX | Sep 30, 2024 | 34.53 | 0.00 |
CTO Realty Growth | CTO | Sep 30, 2024 | 19.02 | +0.16 |
CTO Realty Growth A Pref | CTO-A | Sep 30, 2024 | 23.53 | -1.01 |
CTS | CTS | Sep 30, 2024 | 48.38 | 0.00 |
CubeSmart | CUBE | Sep 30, 2024 | 53.83 | +1.13 |
Cue Biopharma | CUE | Sep 30, 2024 | 0.76 | +11.45 |
Cullen Frost Bankers B Pref | CFR-B | Sep 30, 2024 | 21.70 | +0.74 |
Cullen/Frost Bankers | CFR | Sep 30, 2024 | 111.86 | +0.60 |
Cullinan Therapeutics | CGEM | Sep 30, 2024 | 16.74 | -2.62 |
Cullman Bancorp | CULL | Sep 30, 2024 | 9.71 | 0.00 |
Culp | CULP | Sep 30, 2024 | 6.55 | +9.72 |
Cumberland Pharmaceuticals | CPIX | Sep 30, 2024 | 1.28 | +4.07 |
Cummins | CMI | Sep 30, 2024 | 323.79 | -0.80 |
Cumulus Media A | CMLS | Sep 30, 2024 | 1.31 | -5.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.